SMB
LIVE

Serial Number

98525292

Owner

CEN CO., LTD.

Attorney

Jihun Kim

Filing Date

Apr 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SMB Trademark

Serial Number: 98525292

SMB is a trademark filed by CEN CO., LTD. on April 29, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

CEN CO., LTD. (2 trademarks)

105, 761, Muan-ro, Bubuk-myeon
Miryang-si 50404 , KR

Entity Type: 03

Trademark Details

Filing Date

April 29, 2024

Registration Date

Not Registered

Published for Opposition

December 17, 2024

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; vitamins and mineral supplements; crude medicines for the treatment of gastrointestinal diseases; crude medicines, namely, medicinal preparations for use in dermatology; crude medicines, namely, plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; crude medicines, namely, medicines for treating neurological disease, muscular disease, ischemic disease, renal disease, and cancer; antibacterial pharmaceuticals; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for the treatment of infectious diseases; diagnostic radiopharmaceutical preparations; pharmaceutical drugs for the treatment of metabolic disorders, namely, obesity, comorbidities secondary to obesity, metabolic syndrome, and related metabolic diseases; pharmaceutical drugs for the treatment of joint disorders and osteoarthritis; cough pastilles for pharmaceutical purposes; lotions for pharmaceutical purposes, namely, medicated skin lotions, medicated hair lotions, medicated sunburn lotions, calamine lotion, medicated after-shave lotions, collyrium, anti-bacterial hand lotions; chemical preparations for pharmaceutical use, namely, for the treatment of neurodegenerative disorders, neurological conditions, cancer, skin conditions, or for use in wound healing or photodynamic therapy; chemical preparations for pharmaceutical use, namely, for the treatment of fungal, viral, bacterial and infectious diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2026 EXRA
SOU EXTENSION 2 GRANTED
Feb 10, 2026 EX2G
SOU EXTENSION 2 FILED
Feb 10, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 10, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 28, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 28, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 28, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 20, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 20, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 20, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 20, 2024 CNEA
ASSIGNED TO EXAMINER
Nov 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2024 NWOS
NEW APPLICATION ENTERED
Apr 29, 2024 NWAP